University of Minnesota
Minneapolis, Minnesota, 55455, United States
NCT Number: NCT00000293
The purpose of this study is to determine the effect of nefazodone on relapse to cocaine use in depressed and non-depressed females with cocaine abuse/dependence.
Looking for future studies?
Notify Me18 year–55 year
Female
Interventional
Phase 3
Minneapolis, Minnesota, 55455, United States
The purpose of this study is to determine the effect of nefazodone on relapse to cocaine in women and if a greater effect will be seen in the dependent condition. A relapse and coping skills questionnaire will be utilized to determine the various factors important to the relapse process.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Female, ages 18-55, cocaine abuse/dependence, use of cocaine 7 days of the last 30 days or of the 30 days prior to current abstinence, less than 90 days current abstinence, at least an 8th grade education.
Exclusion criteria
Unstable medical conditions; current use of Hismanal, Seldane, or Propulsid; dx of MR, OBS, bipolar, schizophrenia.
National Institute on Drug Abuse (NIDA)
Nih
Effect of Nefazodone on Relapse in Females With Cocaine Abuse
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02037126
Chemically-Induced Disorders, Cocaine-Related Disorders
Birmingham, Alabama, United States
View Trial DetailsNCT04155632
Chemically-Induced Disorders, Cocaine-Related Disorders
Charleston, South Carolina, United States
View Trial DetailsNCT02773212
Anhedonia, Chemically-Induced Disorders
Chicago, Illinois, United States
View Trial DetailsNCT03953612
Chemically-Induced Disorders, Cocaine-Related Disorders
New Haven, Connecticut, United States
View Trial Details